Eye-Tracking gadget aims to clear confusion in ICU patients
NCT ID NCT06029244
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study tested a wearable eye-tracking device called EyeControl-Pro in 160 older, ventilated ICU patients. The device lets patients communicate by moving their eyes, which may help reduce delirium—a state of confusion common in intensive care. Researchers compared patients who used the device to those who did not, checking for delirium over the first week.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTENSIVE CARE UNIT DELIRIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assuta Ashdod Medical Center
Ashdod, Israel
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Rabin Medical Center
Petah Tikva, Israel
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EyeControl-Pro wearable eye-tracking device
What this could lead to
If it works, this device could help reduce confusion and distress in ICU patients who cannot speak, improving their recovery.
What could go wrong
This is a small, completed trial with 160 patients. The device may not significantly reduce delirium, and results may not apply to all ICU settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.